I. Foundational Topics
1: Awais Aftab and John G. Csernansky: Diagnosis and
conceptualization of mental illness
2: Elizabeth Ryznar and Harvey Whiteford: Epidemiology
II. Pathogenesis
3: Elizabeth Ryznar and Herbert Y. Meltzer: The neurochemical basis
of psychiatric disorders
4: Edwin H. Cook Jr. and Marina Bayeva: Genetics
5: Ozan Toy, Emmalee Boyle, and Lynn E. DeLisi: Inflammatory
mechanisms, the immune system and psychiatric illness
6: Shaun M. Eack: Psychological and social factors
III. Pharmacotherapy
7: David. V. Braitman and Juan. R. Bustillo: Schizophrenia
8: Jair C. Soares, Marsal Sanches, and Rodrigo Machado-Vieira:
Pharmacotherapy of mood disorders
9: Dan J. Stein: Pharmacotherapy of anxiety and related
disorders
10: Jenni E. Farrow, Francisco Romo-Nava, and Melissa Delbello:
Child and adolescent psychiatry
IV. Psychosocial interventions
11: Kevin S. McCarthy and Richard F. Summers: Psychodynamic
therapy
12: Keith S. Dobson: Cognitive behavioral therapy
13: Amanda A. Uliaszek, Nadia Al-Dajani, Amanda Ferguson, and
Zindel V. Segal: Third wave psychotherapies
14: Mariam Ujeyl and Wulf Rössler: Psychosocial rehabilitation
15: Neil Jordan: Social and community psychiatry
16: Mark R. Dadds, Yixin Jiang, Valsamma Eapen, and Stephen Scott:
Child and adolescent psychiatry and psychology
VI. Somatic Treatments
17: Keith G. Rasmussen: Electroconvulsive therapy
18: Kevin A. Caulfield and Mark S. George: Non-convulsive brain
stimulation
19: Paul E. Holtzheimer and Helen Mayberg: Subcallosal cingulate
deep brain stimulation for treatment-resistant depression
VII. Special Considerations
20: Rachel E. Zettl and John Z. Sadler: Psychiatric ethics
21: Stephen H. Dinwiddie: Forensics
22: Danuta Wasserman, Marcus Sokolowski, and Carli Vladimir:
Suicide
23: Robert D. Gibbons: Research methodology
A graduate of Harvard College and Harvard Medical School, Dr.
Elizabeth Ryznar is currently a fourth year psychiatry resident at
the McGaw Medical Center of Northwestern University in Chicago,
where she also completed the Medical Education Clinical Scholars
Program. She received her M.Sc. in Comparative Social Policy from
the University of Oxford and is fluent in Polish and Spanish. Her
clinical and research interests include community psychiatry,
childhood trauma,
psychiatric diagnosis, and medical education. She has published
several peer-reviewed articles and has presented at national
meetings. Dr. Ryznar has been recognized by the American
Psychiatric
Association as a Leadership Fellow (2017-2019) and by the American
College of Psychiatrists as a Laughlin Fellow (2018) and returning
fellow (2019). Dr. Aderonke B. Pederson is a 4th year psychiatry
resident at the McGaw Medical center of Northwestern University,
serving as chief resident. She graduated from University of Chicago
as a double major in biological sciences and international studies.
She completed her medical degree at Northwestern's University
Feinberg school of medicine and was
an American Psychiatric Association diversity leadership fellow in
2017-2018. She is a recipient of federal funding through the APA
SAMHSA fellowship (2018-2019), completing research in minority
mental
health with a focus on mental health stigma among underserved black
minority women in an urban setting. She has reviewed books and
published peer-reviewed articles. She is also working on a global
health certificate program at her institution with a focus in
Nigeria (West Africa) and designed a seminar in West Africa on
mental health stigma awareness among young adults. Professor Mark
A. Reinecke is Chief of Psychology in the Department of Psychiatry
and Behavioral Sciences, Northwestern
University Feinberg School of Medicine, Chicago, Illinois, USA.
Professor John G. Csernansky currently serves as the Gilman
Professor and Chair in the Department of Psychiatry and Behavioral
Sciences at the Northwestern University Feinberg School of
Medicine. Previously, he served as the Gregory B. Couch Professor
of Psychiatry at Washington University School of Medicine. His
research interests include the neuroimaging of neuropsychiatric
disorders, especially schizophrenia, clinical trials of
cognition-enhancing drugs, and the development of new animal
models for neuropsychiatric disorders.
This book is the first of its kind that I have read. I appreciate
how each chapter builds upon itself to provide an overall
understanding of the particular topic. Upon finishing the chapter,
the readers truly have an understanding of the history of the
covered subject matter. There were many topics that presented
seminal findings to which I had not previously been exposed.
*Aaron Plattner, Doody's Book Reviews*
Ask a Question About this Product More... |